167 related articles for article (PubMed ID: 18612144)
1. Chemotherapy for the treatment of children and adolescents with malignant germ cell tumors.
Green DM
J Clin Oncol; 2008 Jul; 26(20):3297-8. PubMed ID: 18612144
[No Abstract] [Full Text] [Related]
2. Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study--Pediatric Oncology Group 9049 and Children's Cancer Group 8882.
Cushing B; Giller R; Cullen JW; Marina NM; Lauer SJ; Olson TA; Rogers PC; Colombani P; Rescorla F; Billmire DF; Vinocur CD; Hawkins EP; Davis MM; Perlman EJ; London WB; Castleberry RP; ;
J Clin Oncol; 2004 Jul; 22(13):2691-700. PubMed ID: 15226336
[TBL] [Abstract][Full Text] [Related]
3. Nondysgerminomatous ovarian tumors: clinical characteristics, treatment, and outcome. A case-controlled study.
Ghaemmaghami F; Hasanzadeh M; Karimi Zarchi M; Fallahi A
Int J Surg; 2008 Oct; 6(5):382-6. PubMed ID: 18715834
[TBL] [Abstract][Full Text] [Related]
4. Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis.
Westermann DH; Schefer H; Thalmann GN; Karamitopoulou-Diamantis E; Fey MF; Studer UE
J Urol; 2008 Jan; 179(1):163-6. PubMed ID: 18001800
[TBL] [Abstract][Full Text] [Related]
5. High dose chemotherapy in germ cell tumors.
Rosti G; De Giorgi U
Tunis Med; 2005 Dec; 83 Suppl 12():85-6. PubMed ID: 16430076
[No Abstract] [Full Text] [Related]
6. Bleomycin, etoposide, and cisplatin for three cycles compared with etoposide and cisplatin for four cycles in good-risk germ cell tumors: is there a preferred regimen?
Einhorn LH; Foster RS
J Clin Oncol; 2006 Jun; 24(16):2597-8; author reply 2598-9. PubMed ID: 16735718
[No Abstract] [Full Text] [Related]
7. Alternatives to standard BEP x 3 in good-prognosis germ cell tumors--you bet your life.
Nichols C; Kollmannsberger C
J Natl Cancer Inst; 2010 Aug; 102(16):1214-5. PubMed ID: 20631340
[No Abstract] [Full Text] [Related]
8. Randomized trial comparing bleomycin/etoposide/cisplatin with alternating cisplatin/cyclophosphamide/doxorubicin and vinblastine/bleomycin regimens of chemotherapy for patients with intermediate- and poor-risk metastatic nonseminomatous germ cell tumors: Genito-Urinary Group of the French Federation of Cancer Centers Trial T93MP.
Culine S; Kramar A; Théodore C; Geoffrois L; Chevreau C; Biron P; Nguyen BB; Héron JF; Kerbrat P; Caty A; Delva R; Fargeot P; Fizazi K; Bouzy J; Droz JP;
J Clin Oncol; 2008 Jan; 26(3):421-7. PubMed ID: 18202419
[TBL] [Abstract][Full Text] [Related]
9. A 25-year single institution experience with surgery for primary mediastinal nonseminomatous germ cell tumors.
Kesler KA; Rieger KM; Hammoud ZT; Kruter LE; Perkins SM; Turrentine MW; Schneider BP; Einhorn LH; Brown JW
Ann Thorac Surg; 2008 Feb; 85(2):371-8. PubMed ID: 18222228
[TBL] [Abstract][Full Text] [Related]
10. Neutropenia and fever in patients undergoing combination chemotherapy for malignant germ cell tumors of the ovary.
Chambers SK; Schwartz PE
Obstet Gynecol; 1986 Dec; 68(6):842-6. PubMed ID: 2431369
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin and etoposide in childhood germ cell tumor: brazilian pediatric oncology society protocol GCT-91.
Lopes LF; Macedo CR; Pontes EM; Dos Santos Aguiar S; Mastellaro MJ; Melaragno R; Vianna SM; Lopes PA; Mendonça N; de Assis Almeida MT; Sonaglio V; Ribeiro KB; Santana VM; Schneider DT; de Camargo B
J Clin Oncol; 2009 Mar; 27(8):1297-303. PubMed ID: 19164215
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of malignant ovarian germ cell tumor and sex cord tumors].
Sugiyama T; Ohta S; Tomonari R; Kamura T
Gan To Kagaku Ryoho; 2002 Aug; 29(8):1358-62. PubMed ID: 12214461
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy for good-risk germ cell tumors: current concepts and controversies.
Vaughn DJ
Urol Clin North Am; 2007 May; 34(2):171-7; abstract viii-ix. PubMed ID: 17484922
[TBL] [Abstract][Full Text] [Related]
14. Bleomycin, vincristine, cisplatin/bleomycin, etoposide, cisplatin chemotherapy: an alternating, dose intense regimen producing promising results in untreated patients with intermediate or poor prognosis malignant germ-cell tumours.
Anthoney DA; McKean MJ; Roberts JT; Hutcheon AW; Graham J; Jones W; Paul J; Kaye SB
Br J Cancer; 2004 Feb; 90(3):601-6. PubMed ID: 14760371
[TBL] [Abstract][Full Text] [Related]
15. [Diagnosis and treatment of germ cell tumors of the ovary].
Sawada M; Matsui Y; Okudaira Y
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2489-95. PubMed ID: 6210050
[TBL] [Abstract][Full Text] [Related]
16. Germ cell tumors in children: gonadal and extragonadal.
Wollner N; Ghavimi F; Wachtel A; Luks E; Exelby P; Woodruff J
Med Pediatr Oncol; 1991; 19(4):228-39. PubMed ID: 1711647
[TBL] [Abstract][Full Text] [Related]
17. [The role of chemotherapy in the treatment of testicular cancer with the exception of seminomas].
Kenis Y; Piccart M; Beer M
Rev Med Brux; 1983 Apr; 4(4):219-23. PubMed ID: 6192477
[No Abstract] [Full Text] [Related]
18. High-dose chemotherapy in nonseminomatous germ cell cancer.
Kollmannsberger C; Beyer J; Bokemeyer C
BJU Int; 2009 Nov; 104(9 Pt B):1398-403. PubMed ID: 19840020
[No Abstract] [Full Text] [Related]
19. Malignant sacrococcygeal germ cell tumors in children: a 30-year experience from a single institution.
Büyükpamukçu M; Varan A; Küpeli S; Ekinci S; Yalcin S; Kale G; Yalçin B; Kutluk T; Akyüz C
Tumori; 2013; 99(1):51-6. PubMed ID: 23549000
[TBL] [Abstract][Full Text] [Related]
20. Variation in bleomycin hydrolase gene is associated with reduced survival after chemotherapy for testicular germ cell cancer.
de Haas EC; Zwart N; Meijer C; Nuver J; Boezen HM; Suurmeijer AJ; Hoekstra HJ; van der Steege G; Sleijfer DT; Gietema JA
J Clin Oncol; 2008 Apr; 26(11):1817-23. PubMed ID: 18398146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]